Cited by 78SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinationsCOVID-19 Clinical Research Studies

Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection

Open access
Abayasingam, Arunasingam, Balachandran, Harikrishnan, Agapiou, David, Hammoud, Mohamed, Rodrigo, Chaturaka, Keoshkerian, Elizabeth, Li, Hui, Brasher, Nicholas A. +23 more·2021·Cell Reports Medicine

Abstract

Considerable concerns relating to the duration of protective immunity against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) exist, with evidence of antibody titers declining rapidly after infection and reports of reinfection. Here, we monitor the antibody responses against SARS-CoV-2 receptor-binding domain (RBD) for up to 6 months after infection. While antibody titers are maintained, ∼13% of the cohort's neutralizing responses return to background. However, encouragingly, in a selected subset of 13 participants, 12 have detectable RBD-specific memory B cells and these generally are increasing out to 6 months. Furthermore, we are able to generate monoclonal antibodies with SARS-CoV-2 neutralizing capacity from these memory B cells. Overall, our study suggests that the loss of neutralizing antibodies in plasma may be countered by the maintenance of neutralizing capacity in the memory B cell repertoire.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xcrm.2021.100228

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Memory B cells might contribute to the durability of antibody responses.

    “Memory B cells might contribute to the durability of antibody responses38,39; B cell germinal centre responses and the durability of protective efficacy following CV2CoV vaccination remain to be determined.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 42 · Cited by 78

Authors
Abayasingam, A., Balachandran, H., Agapiou, D., Hammoud, M., Rodrigo, C., Keoshkerian, E., Li, H., Brasher, N. A., Christ, D., Rouet, R., Burnet, D., Grubor-Bauk, B., Rawlinson, W., Turville, S., Aggarwal, A., Stella, A. O., Fichter, C., Brilot, F., Mina, M., Post, J. J., Hudson, B., Gilroy, N., Dwyer, D., Sasson, S. C., Tea, F., Pilli, D., Kelleher, A., Tedla, N., Lloyd, A. R., Martinello, M., & Bull, R. A.
Affiliations
  • UNSW Sydney (AU)
  • Garvan Institute of Medical Research (AU)
  • The University of Sydney (AU)
  • Northern Beaches Hospital (AU)
  • Royal North Shore Hospital (AU)
  • Westmead Hospital (AU)
  • Blacktown & Mount Druitt Hospital (AU)
Corresponding author
Bull, Rowena A.
Venue
Cell Reports Medicine
Publisher
Elsevier BV
Published
2021-04
Volume
2
Issue
4
Pages
100228
ISSN
2666-3791 (ISSN-L)
OpenAlex
W3137146274
Cited by
78
References
42
Citations by year
2026: 2 · 2025: 6 · 2024: 5 · 2023: 10 · 2022: 23 · 2021: 32
FWCI
5.54
Type
journal article
Language
en
Open access
Locations
  • Cell Reports Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
Funders
  • Royal North Shore Hospital
  • Australian Government
  • Marie Bashir Institute, University of Sydney
  • Department of Health and Ageing, Australian Government
  • University of New South Wales
  • University of Sydney
  • NSW Health Pathology
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, memory B cells, neutralizing antibodies, receptor binding domain, antibody persistence, antibody waning, monoclonal antibodies, humoral immunity, reinfection, long-term immunity
MeSH terms
Protein Domains, COVID-19, SARS-CoV-2, Memory B Cells, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neutralization Tests, Severity of Illness Index, Time Factors, Young Adult, Antibodies, Neutralizing, Limit of Detection, Asymptomatic Diseases, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review